{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:08:21Z","timestamp":1791374901944,"version":"4.3.1"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T00:00:00Z","timestamp":1713484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.virusres.2024.199378","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T23:07:26Z","timestamp":1713913646000},"page":"199378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A live attenuated influenza B virus vaccine expressing RBD elicits protective immunity against SARS-CoV-2 in mice"],"prefix":"10.1016","volume":"345","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9659-1815","authenticated-orcid":false,"given":"Zhenfei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Entao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feihu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiecheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songtao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhu","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2024.199378_bib0001","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.immuni.2020.03.007","article-title":"SARS-CoV-2 vaccines: status report","volume":"52","author":"Amanat","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.virusres.2024.199378_bib0002","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7150\/ijbs.52569","article-title":"Current advances in the development of SARS-CoV-2 vaccines","volume":"17","author":"Awadasseid","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.virusres.2024.199378_bib0003","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.antiviral.2014.01.022","article-title":"Influenza virus vaccine expressing fusion and attachment protein epitopes of respiratory syncytial virus induces protective antibodies in BALB\/c mice","volume":"104","author":"Bian","year":"2014","journal-title":"Antiviral Res"},{"key":"10.1016\/j.virusres.2024.199378_bib0004","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3389\/fimmu.2019.01605","article-title":"Innovative mucosal vaccine formulations against influenza A virus infections","volume":"10","author":"Calzas","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virusres.2024.199378_bib0005","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.coviro.2020.10.005","article-title":"Reverse genetics for influenza B viruses and recent advances in vaccine development","volume":"44","author":"Cardenas-Garcia","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virusres.2024.199378_bib0006","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00689-22","article-title":"A virion-based combination vaccine protects against influenza and SARS-CoV-2 disease in mice","volume":"96","author":"Chaparian","year":"2022","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2024.199378_bib0007","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/j.scib.2022.05.018","article-title":"A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2","volume":"67","author":"Chen","year":"2022","journal-title":"Sci. Bull."},{"key":"10.1016\/j.virusres.2024.199378_bib0008","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41591-021-01294-w","article-title":"Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies","volume":"27","author":"Chen","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2024.199378_bib0009","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1128\/JVI.78.4.1865-1872.2004","article-title":"The influenza B virus nonstructural NS1 protein is essential for efficient viral growth and antagonizes beta interferon induction","volume":"78","author":"Dauber","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2024.199378_bib0010","doi-asserted-by":"crossref","first-page":"32973","DOI":"10.1038\/srep32973","article-title":"Sterilizing immunity to influenza virus infection requires local antigen-specific T cell response in the lungs","volume":"6","author":"Dutta","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.virusres.2024.199378_bib0011","doi-asserted-by":"crossref","first-page":"10580","DOI":"10.1128\/JVI.01213-08","article-title":"Influenza B virus NS1-truncated mutants: live-attenuated vaccine approach","volume":"82","author":"Hai","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2024.199378_bib0012","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.08.026","article-title":"A single-dose intranasal ChAd vaccine protects upper and lower respiratory tracts against SARS-CoV-2","volume":"183","author":"Hassan","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.virusres.2024.199378_bib0013","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41579-020-00459-7","article-title":"Characteristics of SARS-CoV-2 and COVID-19","volume":"19","author":"Hu","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virusres.2024.199378_bib0014","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.tim.2018.05.013","article-title":"Influenza virus","volume":"26","author":"Hutchinson","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.virusres.2024.199378_bib0015","article-title":"Attenuated recombinant influenza A virus expressing HPV16 E6 and E7 as a novel therapeutic vaccine approach","volume":"10","author":"Jindra","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.virusres.2024.199378_bib0016","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-018-0002-y","article-title":"Influenza","volume":"4","author":"Krammer","year":"2018","journal-title":"Nat. Rev. Dis. Primers."},{"key":"10.1016\/j.virusres.2024.199378_bib0017","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.chom.2020.12.010","article-title":"Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models","volume":"29","author":"Ku","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.virusres.2024.199378_bib0018","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2024.199378_bib0019","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/s41586-021-04188-6","article-title":"The emergence, genomic diversity and global spread of SARS-CoV-2","volume":"600","author":"Li","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.virusres.2024.199378_bib0020","first-page":"404","article-title":"[Effect of deletion of the carboxyl terminal of the NS1 protein on pathogenicity of the influenza B virus]","volume":"31","author":"Li","year":"2015","journal-title":"Bing Du Xue Bao"},{"key":"10.1016\/j.virusres.2024.199378_bib0021","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41541-021-00320-9","article-title":"Intranasal powder live attenuated influenza vaccine is thermostable, immunogenic, and protective against homologous challenge in ferrets","volume":"6","author":"Luczo","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.virusres.2024.199378_bib0022","article-title":"Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: an open-label partially-randomised ascending dose phase I trial","volume":"83","author":"Madhavan","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.virusres.2024.199378_bib0023","doi-asserted-by":"crossref","first-page":"e18995","DOI":"10.1371\/journal.pone.0018995","article-title":"Recombinant influenza A virus expressing domain III of the West Nile virus induces protective immune responses against influenza and West Nile virus","volume":"6","author":"Martina","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.virusres.2024.199378_bib0024","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/cbdd.14035","article-title":"SARS-CoV-2 and its variants of concern including Omicron: a never ending pandemic","volume":"99","author":"Mohapatra","year":"2022","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.virusres.2024.199378_bib0025","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021107786","article-title":"The molecular basis of cross-species ACE2 interactions with SARS-CoV-2-like viruses of pangolin origin","volume":"40","author":"Niu","year":"2021","journal-title":"The EMBO J"},{"key":"10.1016\/j.virusres.2024.199378_bib0026","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/ijms18010020","article-title":"Reverse genetic approaches for the development of influenza vaccines","volume":"18","author":"Nogales","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virusres.2024.199378_bib0027","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41392-022-00992-2","article-title":"Tracking SARS-CoV-2 Omicron diverse spike gene mutations","volume":"7","author":"Ou","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.virusres.2024.199378_bib0028","doi-asserted-by":"crossref","first-page":"eabm5505","DOI":"10.1126\/sciimmunol.abm5505","article-title":"Innate immunological pathways are involved in COVID-19 pathogenesis","volume":"7","author":"Paludan","year":"2022","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.virusres.2024.199378_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102941","article-title":"Immunogenicity and protective efficacy of an intranasal live attenuated vaccine against SARS-CoV-2","volume":"24","author":"Park","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.virusres.2024.199378_bib0030","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.cell.2020.09.037","article-title":"Mapping of neutralizing and immunodominant sites in the SARS-CoV-2 spike receptor-binding domain using structure-guided high-resolution serology","volume":"183","author":"Piccoli","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.virusres.2024.199378_bib0031","doi-asserted-by":"crossref","first-page":"eabl9105","DOI":"10.1126\/sciimmunol.abl9105","article-title":"SARS-CoV-2 infection generates tissue-localized immunological memories in humans","volume":"6","author":"Poon","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.virusres.2024.199378_bib0032","article-title":"Concerning emerging SARS-CoV-2 variants","volume":"8","author":"Sanyaolu","year":"2021","journal-title":"Ther. Adv. Infect. Dis."},{"key":"10.1016\/j.virusres.2024.199378_bib0033","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.immuni.2014.12.007","article-title":"Tissue-resident memory T cells","volume":"41","author":"Schenkel","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.virusres.2024.199378_bib0034","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00408-020-00408-4","article-title":"ACE2: major cell entry receptor for SARS-CoV-2","volume":"198","author":"Scialo","year":"2020","journal-title":"Lung"},{"key":"10.1016\/j.virusres.2024.199378_bib0035","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.777212","article-title":"SARS-CoV-2: emergence of new variants and vaccine effectiveness","volume":"11","author":"Singh","year":"2021","journal-title":"Front. Cell Infect. Microbiol."},{"key":"10.1016\/j.virusres.2024.199378_bib0036","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1038\/s41467-022-30913-4","article-title":"Expansion of cytotoxic tissue-resident CD8(+) T cells and CCR6(+)CD161(+) CD4(+) T cells in the nasal mucosa following mRNA COVID-19 vaccination","volume":"13","author":"Ssemaganda","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virusres.2024.199378_bib0037","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/infdis\/jir613","article-title":"Influenza B virus with a modified hemagglutinin cleavage site as a novel attenuated live vaccine","volume":"204","author":"Stech","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virusres.2024.199378_bib0038","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms9020259","article-title":"Safety, immunogenicity, and protective efficacy of the chimeric A\/B live-attenuated influenza vaccine in a mouse model","volume":"9","author":"Stepanova","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.virusres.2024.199378_bib0039","doi-asserted-by":"crossref","DOI":"10.3390\/v13122420","article-title":"Safety, immunogenicity, and protective efficacy of the H5N1 chimeric cold-adapted attenuated vaccine in a mouse model","volume":"13","author":"Sun","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2024.199378_bib0040","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41423-020-0400-4","article-title":"Characterization of the receptor-binding domain (RBD) of the 2019 novel coronavirus: implications for the development of RBD protein as a viral attachment inhibitor and vaccine","volume":"17","author":"Tai","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.virusres.2024.199378_bib0041","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1080\/22221751.2021.1898291","article-title":"The lessons learned one year after SARS-CoV-2 emergence leading to the COVID-19 pandemic","volume":"10","author":"To","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.virusres.2024.199378_bib0042","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00433-18","article-title":"Avian influenza viruses in wild birds: evolution of viruses in a multi-host ecosystem","volume":"92","author":"Venkatesh","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2024.199378_bib0043","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.587269","article-title":"SARS-CoV-2 structure, biology, and structure-based therapeutic development","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.virusres.2024.199378_bib0044","article-title":"Characterization of Two Heterogeneous Lethal Mouse-Adapted SARS-CoV-2 Variants Recapitulating Representative Aspects of Human COVID-19","volume":"13","author":"Yan","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.virusres.2024.199378_bib0045","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/pro.3909","article-title":"Architecture and self-assembly of the SARS-CoV-2 nucleocapsid protein","volume":"29","author":"Ye","year":"2020","journal-title":"Protein Sci"},{"key":"10.1016\/j.virusres.2024.199378_bib0046","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.bbrc.2020.04.136","article-title":"Biochemical characterization of SARS-CoV-2 nucleocapsid proteins","volume":"527","author":"Zeng","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virusres.2024.199378_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110558","article-title":"Cross-species tropism and the antigenic landscape of circulating SARS-CoV-2 variants","volume":"38","author":"Zhang","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.virusres.2024.199378_bib0048","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S2213-2600(22)00131-X","article-title":"Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomized, double-blind, placebo-controlled, phase 1 and 2 trials","volume":"10","author":"Zhu","year":"2022","journal-title":"Lancet. Respir. Med."}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170224000716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170224000716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T17:36:03Z","timestamp":1716658563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170224000716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":48,"alternative-id":["S0168170224000716"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2024.199378","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A live attenuated influenza B virus vaccine expressing RBD elicits protective immunity against SARS-CoV-2 in mice","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2024.199378","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"199378"}}